Zhou-Yang Xue et al.
COMMUNICATIONS
(0.05 mmol) and the corresponding benzoxazinone
(0.50 mmol) in 2 mL of dry CH2Cl2 and H2O (1.1 mL,
0.12 equiv.) at 08C. The reaction mixture was stirred at 08C
until the reaction stopped. Then the reaction was quenched
with saturated aqueous solution of NaHCO3. The mixture
was extracted with EtOAc and the combined extracts was
washed with brine and dried over anhydrous MgSO4. Con-
centration in vacuum followed by flash chromatography on
silica gel with hexane/ethyl acetate as the eluent afforded
the pure product. The ee values were determined using es-
tablished HPLC techniques with chiral stationary phases.
A. H. Tang, P. F. VonVoigtlander, J. D. Petke, J. Med.
Chem. 1996, 39, 158–175; b) R. E. TenBrink, W. B. Im,
V. H. Sethy, A. H. Tang, D. B. Carters, J. Med. Chem.
1994, 37, 758–768; c) K. S. Kim, L. Qian, J. E. Bird,
K. E. J. Dickinson, S. Moreland, T. R. Schaeffer, T. L.
Waldron, C. L. Delaney, H. N. Weller, A. V. Miller, J.
Med. Chem. 1993, 36, 2335–2342; d) S. N. Falling H.
Rapoport, J. Org. Chem. 1980, 45, 1260–1270.
[3] For selected examples, see: a) S. Yamazaki, Y. Iwata, Y.
Fukushima, Org. Biomol. Chem. 2009, 7, 655–659;
b) H. Miyabe, Y. Yamaoka, Y. Takemoto, J. Org.
Chem. 2006, 71, 2099–2106; c) F. G. West, B. N. Naidu,
J. Org. Chem. 1994, 59, 6051–6056; d) T. Nishio, Y.
Omote, J. Org. Chem. 1985, 50, 1370–1373; e) H.
Bartsch, O. Schwarz, J. Heterocycl. Chem. 1983, 20, 45–
48; f) D. G. Orphanos, A. Taurins, Can. J. Chem. 1966,
44, 1795–1800; g) S. Kamila, E. R. Biehl, Heterocycles
2006, 68, 1931–1939; h) J. Oble, L. El Kaim, M. Gizzi,
L. Grimaud, Heterocycles 2007, 73, 503–517.
[4] a) J. Wolfer, T. Bekele, C. J. Abraham, C. Dogo-Isona-
gie, T. Lectka, Angew. Chem. 2006, 118, 7558–7560;
Angew. Chem. Int. Ed. 2006, 45, 7398–7400; b) D. H.
Paull, E. Alden-Danforth, J. Wolfer, C. Dogo-Isonagie,
C. J. Abraham, T. Lectka, J. Org. Chem. 2007, 72,
5380–5382: c) C. J. Abraham, D. H. Paull, M. T.
Scerba, J. W. Grebinski, T. Lectka, J. Am. Chem. Soc.
2006, 128, 13370–13371; d) D. Paull, J. Wolfer, J. W.
Grebinski, A. Weatherwax, T. Lectka, Chimia 2007, 61,
240–246.
General Procedure for Enantioselective
Hydrosilylation of Quinoxalinones 4a–4q (Table 5)
Trichlorosilane (102 mL, 0.6 mmol, 2.0 equiv., dissolved in
0.3 mL of CHCl3.) was added to a solution of the catalyst
(0.03 mmol) and the corresponding quinoxalinone
(0.3 mmol) in 2 mL of dry CHCl3 at 08C. The reaction mix-
ture was stirred at 08C until the reaction stopped. Then the
reaction was quenched with saturated aqueous solution of
NaHCO3. The mixture was extracted with EtOAc and the
combined extracts was washed with brine and dried over an-
hydrous MgSO4. Concentration in vacuum followed by flash
chromatography on silica gel with hexane/ethyl acetate as
the eluent afforded the amine. The ee values were deter-
mined using established HPLC techniques with chiral sta-
tionary phases.
[5] a) M. Rueping, A. P. Antonchick, T. Theissmann,
Angew. Chem. 2006, 118, 6903–6907; Angew. Chem.
Int. Ed. 2006, 45, 6751–6755; b) M. Rueping, F, Tato,
F. R. Schoepke, Chem. Eur. J. 2010, 16, 2688–2691.
[6] R. I. Storer, D. E. Carrera, Y. Ni, D. W. C. MacMillan,
J. Am. Chem. Soc. 2006, 128, 84–86.
[7] For reviews on Lewis base activation of Lewis acids,
see: a) S. Rendler, M. Oestreich, Synthesis 2005, 1727–
1747; b) Y. Orito, M. Nakajima, Synthesis 2006, 1391–
1401; c) S. E. Denmark, G. L. Beutner, Angew. Chem.
2008, 120, 1584–1663; Angew. Chem. Int. Ed. 2008, 47,
1560–1638.
Acknowledgements
We are grateful for the financial support from National Sci-
ences Foundation of China (20772122, 20972155) and Na-
tional Basic Research Program of China (973 Program)
(2010CB833301).
References
ˇ
´
[8] For reviews, see: a) P. Kocovsky, A. V. Malkov, Chiral
Lewis Bases as Catalysts, in: Enantioselective Organoca-
talysis, (Ed.: P. I. Dalko), Wiley-VCH, Weinheim, 2007,
p 255; b) H. B. Kagan, Organocatalytic Enantioselective
Reduction of Olefins, Ketones and Imines, in: Enantio-
selective Organocatalysis, (Ed.: P. I. Dalko), Wiley-
VCH, Weinheim, 2007, p 391.
[1] a) H. Daniel, P. William, (P & H Therapeutics Inc.,
USA), U.S. Patent 2009311318 (A1), 2009; b) D. D.
Andrea, E. J. John, (Warner Lambert Co., USA), U.S.
Patent 6,410,536 (B1), 2002; c) D. V. Smil, S. Manku,
Y. A. Chantigny, S. Leit, A. Wahhab, R. Deziel, T. P.
Yan, M. Fournel, C. Maroun, Z. Li, A.-M. Lemieux, A.
Nicolescu, J. Rahil, J. M. Besterman, S. Lefebvre, A.
Panetta, Bioorg. Med. Chem. Lett. 2009, 19, 688–692;
d) P. E. Mahaney, M. B. Webb, F. Ye, J. P. Sabatucci,
R. J. Steffan, C. C Chadwick, D. C. Harnish, E. J. Try-
bulski, Bioorg. Med. Chem. 2006, 14, 3455–3466; e) D.-
S. Su, M. K. Markowitz, R. M. DiPardo, K. L. Murphy,
C. M. Harrell, S. S. OꢀMalley, R. W. Ransom, R. S. L.
Chang, S. Ha, F. J. Hess, D. J. Pettibone, J. Am. Chem.
Soc. 2003, 125, 7516–7517.
ˇ
ˇ
´
[9] a) A. V. Malkov, K. Vrankovꢃ, S. Stoncius, P. Kocovsky,
J. Org. Chem. 2009, 74, 5839–5849; b) Z. Y. Xue, Y.
Jiang, W. C. Yuan, X. M. Zhang, Eur. J. Org. Chem.
2010, 616–619.
[10] a) H. J. Zheng, J. G. Deng, W. Q. Lin, X. M. Zhang, Tet-
rahedron Lett. 2007, 48, 7934–7937; b) H. J. Zheng,
W. B. Chen, Z. J. Wu, J. G. Deng, W. C. Yuan, W. Q.
Lin, X. M. Zhang, Chem. Eur. J. 2008, 14, 9864–9867.
[11] O. Onomura, Y. Kouchi, F. Iwasaki, Y. Matsumura, Tet-
rahedron Lett. 2006, 47, 3751–3754.
[2] a) E. J. Jacobsen, R. E. TenBrink, L. S. Stelzer, K. L.
Belonga, D. B. Carter, H. K. Im, W. B. Im, V. H. Sethy,
2136
ꢁ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 2010, 352, 2132 – 2136